AP103 is based on Amryt's gene-therapy platform technology and offers a potential treatment for patients with DEB... Dec 24
Innovent announces NMPA granted new indication approvals for SULINNO (Adalimumab Injection) for the treatment of pediatric plaque psoriasis and non-infectious uveitis ... Dec 24
-Advertisements-